News Column


July 9, 2014

Item 8.01 Other Events.

On July 9, 2014, Amarantus Bioscience Holdings, Inc. (the "Company") met the conditions to call its outstanding warrants to purchase shares of its common stock at an exercise price of $0.06 per share issued in the Company's private placement offering completed on September 3, 2013 and September 26, 2013 (the "Original Warrants"). The Company will provide notice on or about July 10, 2014 to the holders of the Original Warrants to call the warrants for cancellation at a price of $0.001 per warrant share. As of the date hereof, there are 20,138,810 outstanding Original Warrants. Pursuant to the terms of the Original Warrants, the Company will honor any exercise notices it receives before the 10 trading after the call notice is received by the holders. If the Original warrants are exercised the Company will receive an aggregate of approximately $1,208,329.

On July 9, 2014, the Company also met the conditions to force the conversion of its outstanding 8% Original Issue Discount Senior Convertible Debentures due September 6, 2014 and October 1, 2014 (the "Debentures"). As of the date hereof, the Company has a principal aggregate amount of $166,667 Debentures outstanding. The Company intends to provide notice to the holders of the Debentures on or about July 10, 2014 to force such conversion.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters